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DHEC Resources for Ebola  
Virus Disease
Keep up with Public Health’s recommendations 
on preparation for and responding to the Ebola 
outbreak in West Africa. Additional information and 
archives sent via the Health Preparedness Network 
(HPN) are available on the DHEC Ebola webpage at: 
www.scdhec.gov/ebola.
South Carolina 2015 List of  
Reportable Conditions
Chasisity B. Springs, PhD 
Surveillance Epidemiologist  
Division of Acute Disease Epidemiology
Michelle L. Myer, DNP, RN, APRN, CPNP 
Epidemiology Nurse Consultant 
Division of Acute Disease Epidemiology
South Carolina Law (44-29-10) and Regulations (61-20) 
require reporting of specified contagious and infectious 
diseases and conditions to the health department. 
In South Carolina, these diseases and conditions 
are specified in the List of Reportable Conditions, 
published annually. The list is available in printed 
form from DHEC’s Public Health Regional Epi Offices, 
and online from the DHEC website at www.scdhec.
gov/Health/FHPF/ReportDiseasesAdverseEvents/
ReportableConditionsInSC.
The List of Reportable 
Conditions specifies which 
illnesses are reported, within 
which time frames, and to 
where reports are to be 
made.
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Updates to the List of Reportable 
Conditions for 2015
New “catch-all” statement for outbreaks and 
other unusual events
The requirement to report “Any outbreak or unusual 
disease” or “Any intentional biological, chemical, 
or radiological event” has been replaced with “Any 
case that may be caused by chemical, biological, or 
radiological threat, novel infectious agent, or any cluster 
of cases, or outbreak of disease or condition that might 
pose a substantial risk of human morbidity or mortality.”
New Conditions Added
• Chikungunya has been added as urgently reportable 
within 24 hours. Send isolates, positive serologies, or 
specimens to the DHEC Bureau of Laboratories for 
confirmatory testing or genotyping.
• Ciguatera (also called Ciguatera Fish Poisoning) has 
been added as urgently reportable within 24 hours.
• Clostridium difficile has been added as routinely 
reportable, within 3 days. Reporting is required by 
laboratories, only. See the article on C. diff reporting 
on page 7.
Condition Removed
• Meningoencephalitis, aseptic, also called aseptic 
meningitis, has been removed from the list. This 
condition, which is not nationally reportable, did 
not have a clear case definition, and thus was 
inconsistently reported. 
Additional Reporting Required/Clarified
• Drug susceptibility profiles are to be reported for 
the following isolates:
• Campylobacteriosis
• Gonorrhea
• Influenza
• Meningococcal disease
• Salmonellosis
• Shigellosis
• Staphylococcus aureus, vancomycin-resistant or 
intermediate resistant
• Streptococcus Group A invasive Disease
• Streptococcus Group B, under 90 days of age
• Streptococcus pneumoniae, invasive
• Typhoid Fever (Salmonella Typhi)
• Requirement to submit specimens to DHEC’s 
Bureau of Laboratories: 
 
The wording “Labs are requested to submit these 
isolates, positive serologies, or specimens to the 
DHEC Bureau of Laboratories for confirmatory 
testing or genotyping” has been revised to “Labs 
must submit these isolates, positive serologies, or 
specimens to the DHEC Bureau of Laboratories for 
confirmatory testing or genotyping.”
Clarifications for Reportable Conditions
• For clarity, the reportable condition “E. coli, shiga 
toxin-producing (STEC), including E. coli O157:H7” 
has been revised to “Escherichia coli, Shiga toxin-
producing (STEC).”
• Hemolytic uremic syndrome (HUS) has been changed 
to Hemolytic uremic syndrome (HUS), post-diarrheal. 
Cases of HUS that do not occur after a diarrheal 
illness are not reportable to DHEC.
Reporting Reminders
1. What to Report
For all suspected and confirmed cases, report the 
following (bolded information is new or revised):
• Patient’s name
• Patient’s complete address, phone number, 
county, date of birth, race, sex, and last FIVE 
digits of their social security number
• Physician’s name and phone number
• Name, institution, and phone number of person 
reporting
• Disease or condition
• Date of diagnosis
• Symptoms
• Date of onset of symptoms
• Lab results, specimen site, collection date
• If female, pregnancy status
• Patient status: In childcare, food-handler, health 
care worker, childcare worker, nursing home, 
prisoner/detainee, and travel in last 4 weeks
2. How to Report
This section’s layout was updated to clarify where 
specific conditions should be reported.
• HIV, AIDS, and STD reports are called in  
(1-800-277-0873) or mailed to the Division of 
Surveillance and Technical Support.
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• Lead test results are mailed to the Division of 
Children’s Health.
• TB results are called in to the TB Control Division 
(803-898-0558).
• Routinely reportable diseases other than HIV/
AIDS/STDs, Lead, or TB should be faxed or mailed 
to your Regional DHEC Office. Mailing addresses 
and fax numbers are provided.
• Daytime and night/weekend/holiday phone 
numbers are provided. Urgently and 
immediately reportable conditions must be 
called in to DHEC’s Regional Epi Offices.
– Low Country: (843) 441-1091
– Midlands: (888) 801-1046
– Pee Dee: (843) 915-8845
– Upstate: (866) 298-4442
2015 Disease Reporting Form
A few edits were made to the 2015 DHEC Disease 
Reporting Form (the 1129 card) to assure accurate 
reporting.
• Dates
• Under Laboratory Information, “Report Date” has 
been changed to “Result Date”. 
• “Date Reported to Health Department” has been 
dropped. This has been replaced with “Today’s 
Date” which is now at the top of the form.
• Reporter Information
• “Responsible Physician Name” has been changed 
to “Ordering Physician Name.” This will assist 
DHEC with follow up investigations regarding 
testing ordered by a provider who did not retain 
primary responsibility for the care of the patient.
• Reporting Facility Address has been added.
• Patient Identifying Information
• Reporters are asked to provide the last FIVE (not 
six) digits of the patient’s social Security Number.
• Other
• The items in the “DHEC Use Only” fields were 
deleted.
The Disease Reporting Forms are available from the 
DHEC website at www.scdhec.gov/library/D-1129.pdf.
Links for Disease Reporting Information
Reportable Diseases Page on DHEC website
• www.scdhec.gov/Health/FHPF/
ReportDiseasesAdverseEvents/
ReportableConditionsInSC
PDF List of Reportable Conditions
• www.scdhec.gov/library/CR-009025.pdf 
• Includes contact numbers for daytime and after-hours 
disease reporting
PDF Laboratory List of Reportable Conditions
• www.scdhec.gov/library/CR-009036.pdf
SC DHEC Disease Reporting Form
• www.scdhec.gov/library/D-1129.pdf
Questions?
For questions about Disease Reporting or to discuss 
electronic disease reporting via DHEC’s electronic disease 
surveillance reporting system, call the DHEC Bureau of 
Disease Control in Columbia: 803-898-0861 (M-F 8:30 AM 
to 5 PM).
If female, pregnant?
Yes       No        Unknown
  
 
 
 
 
 
 
 
 
 
 
 
 
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
Last Name                First Name   Middle Name 
Patient ID or last five digits of SSN: ________________________ DOB: ______/______/____________ 
Street Address    
City   State  Zip  County 
Preferred Contact Number  (            ) _________-_________________            Home              Cell             Work 
Ethnicity Sex
Race
2015 SOUTH CAROLINA DEPARTMENT OF HEALTH AND ENVIRONMENTAL CONTROL DISEASE REPORTING FORM
Disease reporting is required by SC Code of Laws Section 44-29-10, 44-53-1380, 44-1-110, and 44-1-140 and Regulation 61-20. See other side for list of reportable diseases.
Federal HIPAA legislation allows disclosure of protected health information, without consent of the individual, to public health authorities for the purpose of preventing or controlling disease.  (45 CFR §164.512)
 
Disease/Condition (include stage, if appropriate): _________________________________________________ Today’s Date____________________________
Hispanic
Non-Hispanic
Unknown
Male
Female
Unknown
Asian
American Indian/
Alaskan Native
Black
Pacific Islander
White
Unknown
Date of diagnosis/bite: ________/_________/_______________
Date of symptom onset: _______/________/________________
Symptoms:
 
                                       Y | N | UNK
Hospitalized
Emergency Room
Died
Date of Death: ______/______/____________
 
If hospitalized, complete: Hospital Name Admit Date         Discharge Date
Treated:         Yes         No       Unk
Date: __________/____________/___________________
Rx: ____________________________________________
For Rabies PEP: 
Animal species: __________________________________
Initial date of administration: /              / 
LABORATORY INFORMATION * Report Hepatitis in Viral Hepatitis box below 
Specimen 
Collection Date
Lab Test Name (ex. Culture, 
IFA, IGM, PCR, Susceptibility) 
Specimen Source
(ex. Stool, Blood, CSF) Result (ex. +/-, titer) Species/Serotype
PATIENT STATUS                 Y | N | UNK
In childcare
Food handler
Healthcare worker
Daycare Worker
Nursing home or other chronic care facility
Prisoner/detainee
Outbreak related
Travel in last 4 weeks
REPORTER INFORMATION
Reporting lab/facility: ____________________________________________________
Reporting facility address: ________________________________________________
Reporter name: ________________________________________________________
Reporter telephone: (          ) ______________-____________________________
Performing lab name: ___________________________________________________
Ordering physician name: ______________________________________________
Physician phone: (        )                     - 
Comments: Mail or Call Reports To:
Reporting required by attending physician/designee and laboratory except where lab only (L) reporting is indicated.
 
*VIRAL HEPATITIS TEST RESULTS          Specimen collection date: ________/_________/__________
ALT ____________________   AST ________________  Result date: ________/_________/__________
Jaundice:           Yes            No                          Pos | Neg |  UNK
Hepatitis A Total anti-HAV
                          IgM anti-HAV
                           
                          HBsAg
Hepatitis B HBV NAT
                          HBeAG
                          IgM anti-HAB
                         
                          HCV RNA (PCR, bDNA) 
Hepatitis C HCV (EIA)
                                                  
                                                 anti-HCV signal to cut-off ratio ________________
Other:
 
Result Date
DHEC 1129 (12/2014)
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Flu Seasons are Unpredictable:  
A Look Back at Influenza Activity 
and What Providers Need to 
Know Today
Linda J. Bell, MD 
State Epidemiologist
Anna-Kathryn Rye, MD 
Medical Consultant 
Division of Acute Disease Epidemiology
Heightened interest in flu activity begins in the fall of 
each year and public health officials are typically asked 
to speculate about what the winter will bring based on 
a “typical flu season”. This look back at surveillance 
data from recent flu seasons explains that while some 
prediction is possible, there really is no such thing as a 
typical flu season. Contributors to variation in flu activity 
and severity in populations include: the dominant 
circulating strains, how well matched available vaccine 
is to circulating strains, genetic changes in flu viruses, 
vaccination coverage rates and even the age and health 
of vaccinated individuals.
Scientists analyze the antigenic characteristics of 
circulating flu strains each year to determine the 
composition of flu vaccines for various parts of the 
world; influenza viruses change constantly thus the 
need for annual flu vaccination. Influenza type A 
viruses change in two ways. Antigenic drift results in 
small, gradual genetic changes that produce different 
but closely related influenza type A strains. Antigenic 
shift is an abrupt, major change in an influenza type 
A virus resulting in entirely new hemagglutinin (HA) or 
neuraminidase virus coat proteins. Antigenic drift occurs 
continually, while antigenic shift is uncommon, creating 
novel strains that may cause pandemics. Influenza type 
B viruses change only by more gradual antigenic drift.
Table 1 reviews selected characteristics of recent flu 
seasons and data from the 2014-2015 flu season to 
date; each of the seasons are unique. In 2009 the novel 
H1N1 pandemic strain began circulating and atypical 
characteristics of a flu season with a novel strain were 
seen. Flu activity began in the early Spring rather than 
Fall, and universal susceptibility in the population to 
a new strain resulted in a moderately severe season 
as compared to other recent seasons. As compared 
to some historical pandemics, however, the 2009 
pandemic was relatively mild. 
In the 2010-2011 and 2011–2012 flu seasons, H1N1 
continued to co-circulate with other strains becoming 
a seasonal flu strain. H3N2 strains somewhat 
predictably cause more severe disease. This is shown 
by hospitalizations and deaths in the 2012–2013 and 
the current season to date. Excluding the pandemic flu 
season, peak flu activity ranged from October to March; 
a second wave occurred in two flu seasons. An average 
of 1,173 hospitalizations occurred in South Carolina in 
the previous five flu seasons, with a range of 114 – 1,941. 
Data for hospitalizations are likely to be underestimates 
because all cases are not tested to confirm flu or are 
not coded and reported as flu. An average of 39 deaths 
occurred in the previous five flu seasons with a range of 
1 – 78.
TABLE 1. INFLUENZA SEASON CHARACTERISTICS IN SOUTH CAROLINA 2009—2014
Flu Season Dominant Strain(s) Season Peak &  ILI Activity* 2nd Wave Hospitalizations Deaths
2009—2010 H1N1 (novel pandemic)
Oct—Nov 
6% Yes 1,091 49
2010—2011 H1N1, H3N2, B** Feb 7% No 996 20
2011—2012 H3N2, H1N1 Feb—Mar 1% No 114 1
2012—2013 H3N2 Nov—Dec 6.1%
Yes 
B strain dominant 1,721 46
2013—2014 H1N1 Dec—Jan 6.8% No 1,941 78
2014—2015 
(to date)
H3N2 
(drifted strain)
- 
24.5% -
1,643 
(01/08/14)
38 
(01/08/14)
*Estimated ILI activity - percent of outpatient visits for ILI reported by sentinel providers above a mean percentage baseline (2%) of ILI during non-
influenza weeks. ILI activity is one of several flu surveillance methods. It is highly driven by the number of sentinel providers reporting and may not be 
representative of true flu activity in the community.
**Co-circulating strains occurred. The dominant strain varied from week to week. 
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This flu season disease activity began earlier and 
is more severe so far than in recent years. H3N2 is 
the predominate strain circulating. Unfortunately, 
the predominant H3N2 strain in circulation has 
genetically drifted from the H3N2 vaccine virus.
About 68% of the H3N2 viruses tested by CDC this 
flu season showed a genetic drift from the H3N2 
component of the 2014-2015 developed for the Northern 
Hemisphere quadrivalent and trivalent influenza 
vaccine (A/Texas/50/2012-lilke); the vaccine is not well 
matched to the circulating H3N2 strain. The majority 
of the drifted viruses are antigenically similar to A/
Switzerland/9715293/2013 viruses, the H3N2 component 
in the 2015 Southern Hemisphere influenza vaccine. The 
drifted strain was first detected in the United States in 
early 2014 and has been increasing through the spring 
and summer. There is a strong likelihood that the drifted 
viruses will continue to circulate. Clinicians are urged 
to follow the recommendations for flu prevention. The 
following are key points that a practitioner needs to 
know to help protect their patients this flu season:
• How well the flu vaccine prevents flu illness ranges 
from season to season. Even when the vaccine match 
is very good, vaccine effectiveness varies across the 
population, depending on the age and health of the 
person being vaccinated, when they are vaccinated 
and even, potentially, which vaccine was used. 
• It takes about two weeks for immunity to develop, so 
offering the vaccine as soon as it becomes available 
offers protection if flu activity begins early, but 
vaccine should be offered for as long as flu activity 
continues. 
• The flu vaccine is recommended annually for all 
people 6 months and older who have not yet received 
a vaccine. Flu vaccines offer protection against 
two type A strains and one or two type B strains 
depending on whether the formulation is trivalent 
or quadrivalent. A list of all available formulations 
is found at www.cdc.gov/flu/protect/vaccine/
vaccines.htm. 
• Although the 2014–2015 Northern Hemisphere vaccine 
effectiveness against H3N2 disease is not high this 
year, the 2014-2015 flu vaccine has been found to 
provide some protection against drifted viruses. This 
cross-protection reduces disease severity and the 
likelihood of severe outcomes such as hospitalization 
and death, especially in high-risk individuals. 
• The CDC is re-emphasizing the importance of the use 
of neuraminidase inhibitor antiviral medications when 
indicated for treatment and prevention of influenza. 
• In patients with severe, complicated, or progressive 
illness and in hospitalized patients, antiviral treatment 
might still have some benefits when started after 48 
hours of illness onset. 
• Encourage good hand hygiene and cough etiquette to 
your patients.
• Encourage patients to stay home when they are sick 
to prevent disease spread in the work place and 
congregate settings like schools. 
Seasonal flu vaccine is the most effective way to prevent 
flu. The flu vaccine not only protects those vaccinated, 
but high vaccine coverage rates will protect those who 
are at high risk for serious flu illness but who may have 
a decreased immune response and, very importantly, 
infants younger than 6 months old who are too young to 
get vaccinated are protected.
For additional information about flu guidance for clinicians 
and flu surveillance and activity in South Carolina, please 
visit: www.scdhec.gov/flu.
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Updates to the School and 
Childcare Exclusion List for 2015
Michelle L. Myer, DNP, RN, APRN, CPNP 
Epidemiology Nurse Consultant 
Division of Acute Disease Epidemiology
For 2015, the School and Childcare Exclusion Lists have 
been combined into a single list. The Exclusion List now 
applies to the following groups in out-of-home childcare 
(as defined in S.C. Code Ann. Section 63-13-20), and in 
any public, private, parochial, church or Sunday school 
(SC Reg 61.20):
• Children and employees in out-of-home  
childcare settings; 
• Preschool/kindergarten students in grades 3K, 4K, 
and 5K; 
• Students in grades 1-12; and
• School faculty and staff that have contact  
with students.
The updated School and Childcare Exclusion List, along 
with informational brochures for parents of children in 
school or in out-of-home childcare, is currently available 
on the DHEC website.
As noted in the box above, the Exclusion List, as well 
as brochures in English and Spanish for parents, were 
moved to new locations on the DHEC website. In 
addition to bookmarking these files for quick access, 
typing “Exclusion” into the Search box on the DHEC 
Home Page (www.scdhec.gov) can also help retrieve 
these files.
Please contact the DHEC Division of Acute Disease 
Epidemiology (803-898-0861) with any questions about 
the School and Childcare Exclusion Lists. 
Updates to the List for 2015
Record Keeping Update
The requirement to “maintain a record of students 
known to have been excluded under this regulation” 
has been removed from the document. School or 
childcare providers may opt to continue keeping these 
records, as needed. 
New Condition Added to the List
Cryptosporidiosis: Exclude students and childcare 
staff until diarrhea resolves for at least 24 hours. Exclude 
children with Cryptosporidiosis from recreational water 
activities (pools, splash pads, water tables, etc.) until 2 
weeks after diarrheal symptoms resolve.
Conditions Removed from the List
• Cytomegalovirus
• Infectious Mononucleosis 
While students with these infections are often kept out 
of school when there is a risk of organ damage from 
play, these conditions are not easily spread in the school 
setting. Students with these conditions may attend 
school if they are well enough to participate in routine 
activities.
Sports and PE restrictions may apply to students with 
these conditions.
Exclusion Criteria Clarified or Updated
• Conjunctivitis: Exclusion for conjunctivitis is 
appropriate when staff or students also have fever, 
severe eye pain, or are too sick to participate in 
routine school activities. Encourage persons with 
pinkeye to wash hands frequently and to keep hands 
away from eyes. 
• Diarrhea: While most children and staff with diarrhea 
may return to school once symptoms are resolved 
for 24 hours, additional criteria apply for children 
with diarrhea caused by E. coli, Salmonella Typhi, or 
shigella. Refer to the specific details for each of these 
conditions in the list.
Changes in Return Criteria
• Pertussis: During an outbreak, contacts with cough 
illness – who are suspected of also being pertussis 
cases -- may return after 5 days of appropriate 
antibiotics, after 21 days since last contact with an 
infected person, after a negative pertussis test, or 
(NEW) after a health care provider clears the child 
or staff member to return to school or childcare.
• Shigella in the childcare setting or in 
kindergarten: 1 negative stool culture is required 
(rather then 2). 
 
Children or staff in out-of-home childcare or students 
in any level of kindergarten may return to school or 
childcare 24 hours after diarrhea has ceased and at 
least 1 stool culture is negative for shigella. If a child 
received antibiotics for the shigella infection, stool 
cultures must be collected at least 48 hours after 
cessation of antibiotics.  
NEW Location
School and Childcare Exclusion List and  
Parent Information 
• www.scdhec.gov/Health/FHPF/
SchoolNursesChildcareCenters
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A health care professional must clear children or staff 
in out-of-home childcare or children in kindergarten 
for readmission for all cases of shigellosis. 
 
Due to the severity of this illness, in an outbreak, 
DHEC may change the readmission criteria for 
children and staff with shigellosis.
• Shigella in the School Setting: Shortened 
Exclusion Period and Removal of Testing 
Requirement for Staff and for Most Students 
 
School-age students who have been diagnosed with 
shigella, who have good hand hygiene and the ability 
to self-toilet may return to school after diarrhea has 
stopped for at least 24 hours.  
 
Due to the low infectious dose required to spread 
shigella infection, a student with questionable or 
poor hand hygiene may be required to have at least 
1 shigella-negative stool culture and to be diarrhea-
free for at least 24 hours prior to returning. If the child 
received antibiotics for his or her shigella infection, 
any required cultures must be collected at least 48 
hours after cessation of antibiotics. 
 
School staff with shigella infection are excluded until 
diarrhea has stopped for at least 24 hours. 
 
Due to the severity of this illness, in an outbreak, 
DHEC may change the readmission criteria for 
students and staff with shigellosis.
Required Laboratory Reporting  
of Clostridium difficile Infections 
(CDI)
Katherine Habicht, MPH 
Surveillance Epidemiologist 
Division of Acute Disease Epidemiology
Matthew B. Crist, MD, MPH 
Medical Consultant 
Division of Acute Disease Epidemiology
Clostridium difficile infection (CDI) has been added to 
the 2015 South Carolina List of Reportable Conditions 
for laboratory reporting only. All (inpatient and 
outpatient) Clostridium difficile laboratory identifications 
must be submitted to DHEC through one of the following 
mechanisms: 
• Manual data entry into the Carolinas Health 
Electronic Surveillance System (CHESS);
• Disease report card sent to DHEC with an attached 
laboratory report, or 
• Electronic laboratory report (ELR).
Report positive test results for Clostridium difficile 
toxin detected in stool and the detection method e.g. 
enzyme immunoassay, nucleic acid amplification test, or 
toxigenic culture conducted by the reporting laboratory.
While infection prevention efforts have reduced many 
types of health care-associated infections (HAIs), 
national data indicate that rates of health care-
associated Clostridium difficile not only remain high, but 
also have more than doubled since the year 2000. Those 
most at risk for CDI are persons (especially older adults) 
who take antibiotics and also get medical care. When 
a person takes antibiotics, beneficial intestinal bacteria 
that protect against infection are destroyed for several 
months. During this time, patients can get sick from C. 
difficile picked up from contaminated surfaces or spread 
from a health care provider’s hands. About 25% of CDIs 
are identified in individuals first showing symptoms while 
hospitalized; 75% first show in nursing home patients 
or in people recently cared for in doctors’ offices and 
clinics.
Laboratories that report through manual data entry 
into CHESS or disease report cards must provide 
the following information for each CDI lab report: 
1. Patient’s name
2. Date of birth
3. Patient ID number: last 5 of SSN, if possible, or 
hospital billing number
4. Sex
5. Date of collection of stool
6. Date of positive test result
7. Name of laboratory performing the test
8. Name of hospital/medical office or health care 
institution where the stool specimen was collected
Outbreaks of Health Care  
Associated CDI:
Outbreaks of CDI in health care facilities must be 
immediately reported to DHEC by the facility. Reports 
are made to DHEC’s Regional Epidemiology Office 
for the county listed on the annual List of Reportable 
Conditions.
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Meningococcal Vaccine Update: 
New Vaccine for Serogroup B
Olabisi Badmus, MD, MPH 
Medical Consultant 
Division of Acute Disease Epidemiology
On Oct 29, 2014, the first serogroup B meningococcal 
(MenB) vaccine, Trumenba®, was licensed in the 
United State by the Food and Drug Administration. The 
vaccine is licensed as a three-dose vaccine series for 
individuals between 10 and 25 years of age. Additional 
MenB vaccines are anticipated to receive licensure by 
early 2015. Prior to the licensing of Trumenba®, existing 
meningococcal vaccines provided protection against 
meningococcal serogroups A, C, W, and Y. 
According to the Centers for Disease Control and 
Prevention, about 500 total cases of meningococcal 
disease were reported in the United States in 2012; of 
those cases, 160 were caused by serogroup B. While 
meningococcal disease caused by serogroup B may not 
be highly prevalent, the disease can result in devastating 
sequellae and can even be fatal. Several recent 
outbreaks of MenB disease have occurred on college 
campuses. Most recently in 2013, two universities in 
New Jersey and California experienced outbreaks with a 
combined 13 cases and one death reported. 
There are currently no recommendations for routine 
MenB vaccination. In February 2015, the Advisory 
Committee on Immunization Practices (ACIP) plans to 
discuss and vote on recommendations for the use of 
MenB vaccines in high-risk groups, including those 
with high-risk medical conditions, microbiologists with 
occupational exposure, and use in outbreak response. 
The review of evidence for recommending routine 
vaccination for expanded groups is set to take place 
during the June and October 2015 meetings. 
Suspect cases of invasive meningococcal disease 
are immediately reportable to DHEC, regardless of 
serogroup. For immediately and urgently reportable 
conditions, call your regional DHEC office (contact 
information is available on page 11).
Meaningful Use
Roulla D. Nau, MHA 
Division of Acute Disease Epidemiology
What is Meaningful Use?
Meaningful Use (MU) uses certified electronic health 
record (EHR) technology designed to improve health 
care quality, safety, efficiency, and reduce health 
disparities; to engage patients and families in their 
health care; to improve care coordination; and to 
improve population and public health — all while 
maintaining privacy and security. MU promotes 
the adoption of EHR technology by the health care 
community (health care organizations, doctors’ 
offices, etc). Using EHR technology for syndromic 
surveillance data, electronic lab result reports (ELRs), 
and immunization registries enhances DHEC’s ability 
to conduct disease surveillance and respond to 
public health threats. DHEC is implementing MU and 
conducting a methodical process for all health care 
organizations requesting to submit requested data.
MU Requirements 
MU establishes specific requirements for eligible 
professionals (EPs) and eligible hospitals (EH) that 
must be achieved to qualify for Centers for Medicare & 
Medicaid Services (CMS) Incentive Programs.
The requirements differ based on the type of provider 
(EP vs. EH) and their attestation stage. The table below 
details the public objectives by provider and stage. 
For additional information, visit: 
• www.scdhec.gov/Health/FHPF/MeaningfulUse/
RecordIncentive 
• www.cms.gov/Regulations-and-Guidance/
Legislation/EHRIncentivePrograms/Downloads/
PublicHealthRegistry_Tipsheet-.pdf 
Submit questions regarding meaningful use to 
muhelpdesk@dhec.sc.gov.
TABLE 2. MEANINGFUL USE REQUIREMENTS FOR ELIGIBLE PROFESSIONALS AND ELIGIBLE HOSPITALS
STAGE 1 STAGE 2
Public Health Objective Eligible Providers Eligible Hospitals Eligible Providers Eligible Hospitals
Immunization Registries Optional Optional Required Required
Electronic Lab Reporting (ELR) N/A Optional N/A Required
Syndromic Surveillance Optional Optional Optional Required
Cancer Reporting N/A N/A Optional N/A
Reporting to Specialized Disease Registry N/A N/A Optional N/A
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Prevention of Perinatal Hepatitis 
B Infection
Elona Rhame, RN, MSN, MPH 
Perinatal Hepatitis B Coordinator 
Division of Immunization
The CDC recommends that all pregnant women be 
tested routinely for hepatitis B surface antigen (HBsAg) 
during each pregnancy. HBsAg-positive test results, 
along with mother’s pregnancy status, are reportable  
to DHEC. 
DHEC’s Perinatal Hepatitis B  
Case Management
The DHEC Perinatal Hepatitis B Prevention Program 
provides case management for infants born to HBsAg-
positive mothers. Case managers collaborate with 
prenatal care providers, delivery hospital staff, pediatric 
care providers, and families to ensure that infants 
receive recommended post-exposure prophylaxis and 
post-vaccination serologic testing. 
Management of infants born to  
HBsAg-positive women
• Administer single antigen Hepatitis B vaccine and 
Hepatitis B Immune Globulin (HBIG) (0.5 mL) within 
12 hours of birth
• Complete the vaccine series according to the 
recommended schedule for infants born to HBsAg-
positive mothers 
• Ensure a referral to public health (Perinatal Hepatitis 
B Case Management).
• Conduct post-vaccination serologic testing for anti-
HBs and HBsAg after completion of the vaccine 
series, at age 9-18 months. 
For any questions contact DHEC’s Perinatal Hepatitis 
Prevention Program at 803-898-0712.
Prevention of Congenital  
Syphilis Infection
Chelsea Gonzalez, BSN, MPH 
STD/HIV Nurse Consultant 
Division of STD/HIV 
The CDC recommends that effective prevention 
and detection of congenital syphilis depends on the 
identification of syphilis in pregnant women, including 
routine serologic screening of pregnant women during 
the first prenatal visit, at 28 weeks gestation and 
at delivery. All women who have a positive syphilis 
serology and are pregnant must be reported to DHEC. 
DHEC’s Congenital Syphilis Case 
Management
DHEC Maternal/Child Health Nurses designated in 
each public health region will encourage treatment and 
medical management for prenatal, postpartum, and 
infant patients with reactive syphilis serology. Medical 
follow-up and/or treatment and evaluation of serological 
response will be evaluated. 
Management of infants born to syphilis 
positive women: 
• All seroreactive infants will receive follow-up 
examinations and/or serologic testing by their 
primary care provider every 2-3 months until 
the nontreponemal test becomes nonreactive. 
Nontreponemal antibody titers should decline by 
age 3 months and should be nonreactive by age 6 
months if the infant is not infected. 
• The DHEC maternal/child health nurse will establish 
contact with the mother of the infant.
• The DHEC maternal/child health nurse will perform 
follow-up for mother and infant to include monitoring 
visits kept with medical provider and treatment 
initiated or completed.
• The DHEC maternal/child health nurse will work 
with the mother and infant’s primary care provider 
to ensure all necessary lab work, exams, and/or 
procedures are completed according to current CDC 
recommendations based on the case classification. 
Please contact DHEC’s Division of STD/HIV at  
(803) 898-0749 with any questions.
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Disease Reporting
For immediately and urgently reportable conditions, call 
your regional health department:
• Low Country: 843-441-1091
• Midlands: 888-801-1046
• Pee Dee: 843-915-8845
• Upstate: 866-298-4442
• DHEC Bureau of Disease Control: 803-898-0861 
After-hours: 800-847-0902
Routine reports may be phoned in to your regional 
health department or faxed/mailed on a completed  
2015 South Carolina Department of Health and 
Environmental Control Disease Reporting Form:  
www.scdhec.gov/library/D-1129.pdf 
Contact information including mailing addresses and fax 
numbers are found on the List of Reportable Conditions: 
www.scdhec.gov/library/CR-009025.pdf
Contact the Bureau of Disease Control
Virginie Daguise, PhD, Director 
803-898-0713
Linda Bell, MD, State Epidemiologist 
803-898-0861
Bureau of Disease Control Divisions
Division of Acute Disease Epidemiology 
803-898-0861
Division of Immunization and Prevention 
1-800-277-4687
Division of STD/HIV 
803-898-0749
Division of Surveillance and Technical Support 
803-898-0749
Division of Tuberculosis Control 
803-898-0558
DHEC Bureau of Disease Control 
2100 Bull Street 
Columbia, SC 29201 
www.scdhec.gov 
803-898-0558
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Epi Notes, DHEC’s epidemiology 
publication, is published in an  
internet & email-only format.
Continue to receive our updates:
• To subscribe to the Epi Notes for email delivery, send 
an email to EpiNotes@dhec.sc.gov with “Subscribe” 
in the subject line.
• Epi Notes is also available from the DHEC website:  
www.scdhec.gov/Health/DiseasesandConditions/
ChronicDiseaseData/EPINotes
If you are a health professional interested in 
receiving health notifications from the South 
Carolina Health Alert Network, please email 
SCHAN@dhec.sc.gov
FLU WATCH
Flu season has arrived. Be sure to check DHEC’s 
weekly Flu Watch for updates on influenza 
activity in South Carolina.
• Type “Flu in SC” in the search box on DHEC’s 
home page, or
• Bookmark DHEC’s 2013-2014 Flu in South 
Carolina page in your browser:  
www.scdhec.gov/Health/
DiseasesandConditions/InfectiousDiseases/
Flu/FluData
